About
Douglas Vaughan, MD is a physician-scientist focused on aging biology, cardiovascular medicine, and translational therapeutics. He serves as Chief Scientific Officer of Zoe Biosciences, which is developing therapies targeting PAI-1 and APJ for cardiometabolic disease. Public sources also identify him as the founding director of Northwestern University's Potocsnak Longevity Institute and a former chair of medicine at Northwestern.
Areas of interest
longevitybiological aginghealthspancardiologytranslational medicinehuman longevity measurementPAI-1 biologykidney disease and aging